APA (7th ed.) Citation

A, M., C, C., C, G., S, G., N, B., C, H., . . . RA, L. (2026). The polyamine inhibitor SAM486A increases the efficacy of adagrasib in non-small cell lung cancer cells harboring KRASG12C mutation. Biological research, 59(1), . https://doi.org/10.1186/s40659-026-00679-w

Chicago Style (17th ed.) Citation

A, Martin-Martin, et al. "The Polyamine Inhibitor SAM486A Increases the Efficacy of Adagrasib in Non-small Cell Lung Cancer Cells Harboring KRASG12C Mutation." Biological Research 59, no. 1 (2026). https://doi.org/10.1186/s40659-026-00679-w.

MLA (9th ed.) Citation

A, Martin-Martin, et al. "The Polyamine Inhibitor SAM486A Increases the Efficacy of Adagrasib in Non-small Cell Lung Cancer Cells Harboring KRASG12C Mutation." Biological Research, vol. 59, no. 1, 2026, https://doi.org/10.1186/s40659-026-00679-w.